Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Motesanib in Japanese Patients with Advanced GIST
NCT00254267Phase 2Completed
- Sponsor
- Amgen
- Start
- Nov 2005
- Primary completion
- Feb 2007
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of motesanib in gastrointestinal stromal tumor (GIST), sponsored by Amgen. Started Nov 2005; status: completed.
02
Drugs
motesanib
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT00254267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00254267.